LMEN: Capsaicin patch (Qutenza) for peripheral diabetic neuropathy

· London Medicines Evaluation Network

Capsaicin 8% cutaneous patch (Qutenza) is used to treat peripheral neuropathy (PN) in adults. Qutenza was approved in May 2009 for the treatment of non-diabetic adults with PN. In September 2015 the licence was extended to include diabetic patients. This review presents the evidence which supports this licence variation.

NOTE: The content of this resource has not been updated since the publication date. Some information may be out of date and links to other documents or website may not work.

Attachments